Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Hartmann, N. Wagner, A. Rabenhorst, Liselotte Pflanz, S. Leja, A. Förster, M. Gehring, A. Kapp, U. Raap (2013)
Serum IL-31 levels are increased in a subset of patients with mastocytosis and correlate with disease severity in adult patients.The Journal of allergy and clinical immunology, 132 1
C. Ustun, D. DeRemer, C. Akin (2011)
Tyrosine kinase inhibitors in the treatment of systemic mastocytosis.Leukemia research, 35 9
Marcia Taylor, D. Sehgal, M. Raffeld, H. Obiakor, C. Akin, R. Mage, D. Metcalfe (2004)
Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.The Journal of molecular diagnostics : JMD, 6 4
C. Akin, E. Jaffe, M. Raffeld, A. Kirshenbaum, T. Daley, P. Noel, D. Metcalfe (2002)
An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells.American journal of clinical pathology, 118 2
Richard Horan, Richard Horan, K. Austen, K. Austen (1991)
Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.The Journal of investigative dermatology, 96 3
B. Longley, D. Metcalfe, M. Tharp, Xiaomei Wang, L. Tyrrell, Shu-zhuang Lu, David Heitjan, Yongsheng Ma (1999)
Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis.Proceedings of the National Academy of Sciences of the United States of America, 96 4
Peter Valent (1996)
Biology, classification and treatment of human mastocytosis.Wiener klinische Wochenschrift, 108 13
A. Tefferi, chin-Yang Li, J. Butterfield, Hoagland Hc (2001)
Treatment of systemic mast-cell disease with cladribine.The New England journal of medicine, 344 4
P. Valent, C. Akin, M. Arock, K. Brockow, J. Butterfield, M. Carter, M. Castells, L. Escribano, K. Hartmann, P. Lieberman, B. Nedoszytko, A. Órfão, L. Schwartz, K. Sotlar, W. Sperr, M. Triggiani, R. Valenta, H. Horny, D. Metcalfe (2011)
Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus ProposalInternational Archives of Allergy and Immunology, 157
L. Escribano, A. Montero, R. Núñez, A. Órfão (2006)
Flow cytometric analysis of normal and neoplastic mast cells: role in diagnosis and follow-up of mast cell disease.Immunology and allergy clinics of North America, 26 3
M. Miettinen, J. Lasota (2005)
KIT (CD117): A Review on Expression in Normal and Neoplastic Tissues, and Mutations and Their Clinicopathologic CorrelationApplied Immunohistochemistry & Molecular Morphology, 13
J. Cherner, Robert Jensen, Andre Dubois, Thomas O'Dorisio, J. Gardner, D. Metcalfe (1988)
Gastrointestinal dysfunction in systemic mastocytosis. A prospective study.Gastroenterology, 95 3
B. Friedman, G. Darling, J. Norton, L. Hamby, D. Metcalfe (1990)
Splenectomy in the management of systemic mast cell disease.Surgery, 107 1
Cristina Teodosio, A. Mayado, Laura Sa´nchez‐Mun~oz, J. Morgado, M. Jara-Acevedo, Ivan A´lvarez‐Twose, Andre´s Garci´a‐Montero, A. Matito, C. Caldas, L. Escribano, A. Órfão (2015)
The immunophenotype of mast cells and its utility in the diagnostic work‐up of systemic mastocytosisJournal of Leukocyte Biology, 97
P. Valent, C. Akin, W. Sperr, L. Escribano, M. Arock, H. Horny, J. Bennett, D. Metcalfe (2003)
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria.Leukemia research, 27 7
Ken-Hong Lim, A. Tefferi, T. Lasho, C. Finke, M. Patnaik, J. Butterfield, R. Mcclure, chin-Yang Li, A. Pardanani (2009)
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.Blood, 113 23
M. Carter, D. Metcalfe, A. Clark, A. Wayne, I. Maric (2015)
Abnormal bone marrow histopathology in paediatric mastocytosisBritish Journal of Haematology, 168
E. Higgins, S. Humphreys, A. Duvivier (1994)
Urticaria pigmentosa—response to topical steroidsClinical and Experimental Dermatology, 19
Peter Valent, C. Akin, L. Escribano, M. Födinger, K. Hartmann, K. Brockow, M. Castells, W. Sperr, H. Kluin-Nelemans, N. Hamdy, O. Lortholary, J. Robyn, J. Doormaal, Karl Sotlar, A. Hauswirth, M. Arock, O. Hermine, A. Hellmann, M. Triggiani, M. Niedoszytko, L. Schwartz, A. Órfão, Hans-Peter Horny, D. Metcalfe (2007)
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 37
W. Sperr, J. Drach, A. Hauswirth, J. Ackermann, M. Mitterbauer, G. Mitterbauer, M. Foedinger, C. Fonatsch, I. Simonitsch-Klupp, P. Kalhs, P. Valent (2005)
Myelomastocytic Leukemia: Evidence for the Origin of Mast Cells from the Leukemic Clone and Eradication by Allogeneic Stem Cell TransplantationClinical Cancer Research, 11
J. Morgado, O. Perbellini, Ryan Johnson, Cristina Teodosio, A. Matito, I. Alvarez-Twose, P. Bonadonna, A. Zamó, M. Jara-Acevedo, A. Mayado, A. García-Montero, M. Mollejo, T. George, R. Zanotti, A. Órfão, L. Escribano, L. Sánchez-Muñoz (2013)
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosisHistopathology, 63
N. Shah, F. Lee, R. Luo, Yibin Jiang, M. Donker, C. Akin (2006)
Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis.Blood, 108 1
A. Tefferi, M. Elliott, A. Pardanani (2006)
Atypical myeloproliferative disorders: diagnosis and management.Mayo Clinic proceedings, 81 4
W. Sperr, J. Jordan, M. Fiegl, L. Escribano, C. Bellas, S. Dirnhofer, H. Semper, I. Simonitsch-Klupp, H. Horny, P. Valent (2002)
Serum Tryptase Levels in Patients with Mastocytosis: Correlation with Mast Cell Burden and Implication for Defining the Category of DiseaseInternational Archives of Allergy and Immunology, 128
H. Horny, E. Kaiserling, M. Parwaresch, K. Lennert (1992)
Lymph node findings in generalized mastocytosisHistopathology, 21
P. Bonadonna, O. Perbellini, G. Passalacqua, B. Caruso, Sabrina Colarossi, Daniela Fior, L. Castellani, C. Bonetto, F. Frattini, A. Dama, G. Martinelli, M. Chilosi, G. Senna, G. Pizzolo, R. Zanotti (2009)
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.The Journal of allergy and clinical immunology, 123 3
W. Sperr, Luis Escribano, J. Jordan, G. Schernthaner, Michael Kundi, Hans-Peter Horny, Peter Valent (2001)
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis.Leukemia research, 25 7
B. Longley, G. Morganroth, L. Tyrrell, T. Ding, Dirk Anderson, Douglas Williams, R. Halaban (1993)
Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.The New England journal of medicine, 328 18
P. Valent, K. Sotlar, W. Sperr, L. Escribano, S. Yavuz, A. Reiter, T. George, H. Kluin-Nelemans, O. Hermine, J. Butterfield, H. Hägglund, C. Ustun, J. Hornick, M. Triggiani, D. Radia, C. Akin, K. Hartmann, J. Gotlib, L. Schwartz, S. Verstovsek, A. Órfão, D. Metcalfe, M. Arock, H. Horny (2014)
Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.Annals of oncology : official journal of the European Society for Medical Oncology, 25 9
O. Correia, A. Duarte, Paula Quirino, R. Azevedo, L. Delgado (2010)
Cutaneous mastocytosis: Two pediatric cases treated with topical pimecrolimus.Dermatology online journal, 16 5
P. Valent, C. Akin, W. Sperr, H. Horny, D. Metcalfe (2002)
Smouldering Mastocytosis: A Novel Subtype of Systemic Mastocytosis with Slow ProgressionInternational Archives of Allergy and Immunology, 127
Jeffry Lawrence, B. Friedman, William Travis, Vernon Chinchilli, Vernon Chinchilli, D. Metcalfe, Harvey Gralnick (1991)
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis.The American journal of medicine, 91 6
C. Akin, D. Metcalfe (2002)
Surrogate Markers of Disease in MastocytosisInternational Archives of Allergy and Immunology, 127
C. Akin, P. Valent, L. Escribano (2006)
Urticaria pigmentosa and mastocytosis: The role of immunophenotyping in diagnosis and determining response to treatmentCurrent Allergy and Asthma Reports, 6
C. Akin, G. Fumo, A. Yavuz, P. Lipsky, L. Neckers, D. Metcalfe (2004)
A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib.Blood, 103 8
Cristina Teodosio, A. García-Montero, M. Jara-Acevedo, L. Sánchez-Muñoz, I. Alvarez-Twose, R. Núñez, L. Schwartz, A. Walls, L. Escribano, A. Órfão (2010)
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.The Journal of allergy and clinical immunology, 125 3
T. Lehmann, C. Beyeler, B. Lämmle, T. Hunziker, P. Vock, A. Oláh, C. Dahinden, N. Gerber (1996)
Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B.British journal of rheumatology, 35 9
H. Stege, E. Schöpf, T. Ruzicka, J. Krutmann (1996)
High-dose UVA1 for urticaria pigmentosaThe Lancet, 347
O. Godt, E. Proksch, V. Streit, E. Christophers (1997)
Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis.Dermatology, 195 1
Travis Wd, Li Cy (1988)
Pathology of the lymph node and spleen in systemic mast cell disease.Modern Pathology, 1
P. Casassus, N. Caillat-Vigneron, Antoine Martin, J. Simon, V. Gallais, P. Beaudry, V. Eclache, L. Laroche, Pierre Lortholary, M. Raphaël, L. Guillevin, O. Lortholary (2002)
Treatment of adult systemic mastocytosis with interferon‐α: results of a multicentre phase II trial on 20 patientsBritish Journal of Haematology, 119
C. Chen, M. Andrich, J. Mican, D. Metcalfe (1994)
A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 35 9
P. Valent, W. Sperr, P. Samorapoompichit, K. Geissler, K. Lechner, H. Horny, J. Bennett (2001)
Myelomastocytic overlap syndromes: biology, criteria, and relationship to mastocytosis.Leukemia research, 25 7
Kelli Williams, D. Metcalfe, C. Prussin, M. Carter, Hirsh Komarow (2014)
Telangiectasia macularis eruptiva perstans or highly vascularized urticaria pigmentosa?The journal of allergy and clinical immunology. In practice, 2 6
R. Jensen (2000)
Gastrointestinal abnormalities and involvement in systemic mastocytosis.Hematology/oncology clinics of North America, 14 3
A. Pardanani, Ken-Hong Lim, T. Lasho, C. Finke, R. Mcclure, chin-Yang Li, A. Tefferi (2009)
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.Blood, 114 18
M. Carter, J. Robyn, P. Bressler, John Walker, G. Shapiro, D. Metcalfe (2007)
Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis.The Journal of allergy and clinical immunology, 119 6
C. Ustun, J. Gotlib, U. Popat, A. Artz, M. Litzow, A. Reiter, R. Nakamura, H. Kluin-Nelemans, S. Verstovsek, James Gajewski, M. Perales, T. George, T. Shore, W. Sperr, W. Saber, V. Kota, A. Yavuz, V. Pullarkat, J. Rogosheske, W. Hogan, K. Besien, H. Hagglund, G. Damaj, M. Arock, H. Horny, D. Metcalfe, H. Deeg, S. Devine, D. Weisdorf, C. Akin, P. Valent (2016)
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 22 8
H. Moret, E. Plihal, Y. Saudan (1994)
Case report of bone mastocytosis: Total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the kneeClinical Rheumatology, 13
C. D'ambrosio, C. Akin, Yalin Wu, M. Magnússon, D. Metcalfe (2003)
Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.The Journal of allergy and clinical immunology, 112 6
Travis Wd, Li Cy, Bergstralh Ej (1989)
Solid and hematologic malignancies in 60 patients with systemic mast cell disease.Archives of Pathology & Laboratory Medicine, 113
V. Nanagas, A. Kovalszki (2018)
Gastrointestinal Manifestations of Hypereosinophilic Syndromes and Mast Cell Disorders: a Comprehensive ReviewClinical Reviews in Allergy & Immunology
I. Lahortiga, C. Akin, J. Cools, T. Wilson, N. Mentens, D. Arthur, I. Maric, P. Noel, C. Kocabaş, P. Marynen, L. Lessin, I. Wlodarska, J. Robyn, D. Metcalfe (2008)
Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusionHaematologica, 93
W. Sperr, H. Horny, K. Lechner, P. Valent (2000)
Clinical and Biologic Diversity of Leukemias Occurring in Patients with MastocytosisLeukemia & Lymphoma, 37
L. Escribano, C. Akin, M. Castells, L. Schwartz (2006)
Current options in the treatment of mast cell mediator-related symptoms in mastocytosis.Inflammation & allergy drug targets, 5 1
Cristina Chaves-Dias, T. Hundley, A. Gilfillan, A. Kirshenbaum, J. Cunha-Melo, D. Metcalfe, M. Beaven (2001)
Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines1The Journal of Immunology, 166
W. Travis, chin-Yang Li, L. Yam, E. Bergstralh, R. Swee (1988)
Significance of systemic mast cell disease with associated hematologic disordersCancer, 62
C. Dunphy (2005)
Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes.Archives of pathology & laboratory medicine, 129 2
C. Akin, L. Schwartz, T. Kitoh, H. Obayashi, A. Worobec, L. Scott, D. Metcalfe (2000)
Soluble stem cell factor receptor (CD117) and IL-2 receptor alpha chain (CD25) levels in the plasma of patients with mastocytosis: relationships to disease severity and bone marrow pathology.Blood, 96 4
B. Longley, L. Tyrrell, Shu-zhuang Lu, Yong-Sheng Ma, K. Langley, T. Ding, T. Duffy, P. Jacobs, Laura Tang, I. Modlin (1996)
Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 12
K. Hartmann, L. Escribano, C. Grattan, K. Brockow, M. Carter, I. Alvarez-Twose, A. Matito, S. Broesby‐Olsen, F. Siebenhaar, M. Lange, M. Niedoszytko, M. Castells, J. Elberink, P. Bonadonna, R. Zanotti, J. Hornick, A. Torrelo, J. Grabbe, A. Rabenhorst, B. Nedoszytko, J. Butterfield, J. Gotlib, A. Reiter, D. Radia, O. Hermine, K. Sotlar, T. George, T. Kristensen, H. Kluin-Nelemans, S. Yavuz, H. Hägglund, W. Sperr, L. Schwartz, M. Triggiani, M. Maurer, G. Nilsson, H. Horny, M. Arock, A. Órfão, D. Metcalfe, C. Akin, P. Valent (2016)
Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.The Journal of allergy and clinical immunology, 137 1
J. Gotlib, H. Kluin-Nelemans, T. George, C. Akin, K. Sotlar, O. Hermine, F. Awan, E. Hexner, M. Mauro, D. Sternberg, M. Villeneuve, A. Labed, E. Stanek, K. Hartmann, H. Horny, P. Valent, A. Reiter (2016)
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.The New England journal of medicine, 374 26
S. Ueda, H. Ikeda, M. Mizuki, J. Ishiko, I. Matsumura, Hirokazu Tanaka, H. Shibayama, H. Sugahara, Emi Takai, Xian Zhang, T. Machii, Y. Kanakura (2002)
Constitutive Activation of C-kit by the Juxtamembrane but Not the Catalytic Domain Mutations Is Inhibited Selectively by Tyrosine Kinase Inhibitors STI571 and AG1296International Journal of Hematology, 76
A. Toorenenbergen, A. Oranje (2005)
Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.Clinica chimica acta; international journal of clinical chemistry, 359 1-2
J. Velde, F. Vismans, L. LEENHEERS‐BINNENDIJK, C. Vos, D. Smeenk, O. Bijvoet (1978)
The eosinophilic fibrohistiocytic lesion of the bone marrowVirchows Archiv A, 377
L. Schwartz (2006)
Diagnostic value of tryptase in anaphylaxis and mastocytosis.Immunology and allergy clinics of North America, 26 3
A. Yavuz, P. Lipsky, Ş. Yavuz, D. Metcalfe, C. Akin (2002)
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.Blood, 100 2
A. Gilfillan, R. Peavy, D. Metcalfe (2009)
Amplification mechanisms for the enhancement of antigen-mediated mast cell activationImmunologic Research, 43
M. Jawhar, J. Schwaab, Susanne Schnittger, M. Meggendorfer, Markus Pfirrmann, Karl Sotlar, Hans-Peter Horny, G. Metzgeroth, Sebastian Kluger, N. Naumann, C. Haferlach, T. Haferlach, P. Valent, W. Hofmann, A. Fabarius, N. Cross, N. Cross, A. Reiter (2016)
Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosisLeukemia, 30
A. Kirshenbaum, S. Kessler, J. Goff, D. Metcalfe (1991)
Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells.Journal of immunology, 146 5
T. Furitsu, T. Tsujimura, T. Tono, H. Ikeda, H. Kitayama, U. Koshimizu, H. Sugahara, J. Butterfield, L. Ashman, Y. Kanayama (1993)
Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.The Journal of clinical investigation, 92 4
H. Horny, M. Ruck, E. Kaiserling (1992)
Spleen findings in generalized mastocytosis. A clinicopathologic studyCancer, 70
A. Worobec (2000)
Treatment of systemic mast cell disorders.Hematology/oncology clinics of North America, 14 3
F. Ruëff, M. Placzek, B. Przybilla (2006)
Mastocytosis and Hymenoptera venom allergyCurrent Opinion in Allergy and Clinical Immunology, 6
M. Kojima, S. Nakamura, H. Itoh, Y. Ohno, N. Masawa, T. Joshita, T. Suchi (1999)
Mast cell sarcoma with tissue eosinophilia arising in the ascending colon.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 12 7
J. Morgado, L. Sánchez-Muñoz, Cristina Teodosio, M. Jara-Acevedo, I. Alvarez-Twose, A. Matito, E. Fernández-Núñez, A. García-Montero, A. Órfão, L. Escribano (2012)
Immunophenotyping in systemic mastocytosis diagnosis: ‘CD25 positive’ alone is more informative than the ‘CD25 and/or CD2’ WHO criterionModern Pathology, 25
H. Horny, M. Parwaresch, E. Kaiserling, K. Müller, M. Olbermann, K. Mainzer, K. Lennert (1986)
Mast cell sarcoma of the larynx.Journal of Clinical Pathology, 39
C. Akin, P. Valent, D. Metcalfe (2010)
Mast cell activation syndrome: Proposed diagnostic criteria.The Journal of allergy and clinical immunology, 126 6
C. Akin, L. Scott, C. Kocabaş, N. Kushnir-Sukhov, E. Brittain, P. Noel, D. Metcalfe (2007)
Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.Blood, 110 7
R. Gupta, B. Bain, C. Knight (2002)
Cytogenetic and Molecular Genetic Abnormalities in Systemic MastocytosisActa Haematologica, 107
H. Nagata, A. Worobec, C. Oh, B. Chowdhury, S. Tannenbaum, Yoshifumi Suzuki, D. Metcalfe (1995)
Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.Proceedings of the National Academy of Sciences of the United States of America, 92 23
K. Brockow, L. Scott, A. Worobec, A. Kirshenbaum, C. Akin, M. Huber, D. Metcalfe (2002)
Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease.Archives of dermatology, 138 6
T. Daley, D. Metcalfe, C. Akin (2001)
Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin.Blood, 98 3
Anupama Ravi, J. Butterfield, C. Weiler (2014)
Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.The journal of allergy and clinical immunology. In practice, 2 6
D. Rønnov-Jessen, P. Nielsen, T. Horn (1991)
Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome.Bone marrow transplantation, 8 5
M. Taylor, J. Dastych, D. Sehgal, M. Sundstrom, G. Nilsson, C. Akin, R. Mage, D. Metcalfe (2001)
The Kit-activating mutation D816V enhances stem cell factor--dependent chemotaxis.Blood, 98 4
R. Nakamura, S. Chakrabarti, C. Akin, J. Robyn, E. Bahceci, A. Greene, R. Childs, C. Dunbar, D. Metcalfe, A. Barrett (2006)
A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosisBone Marrow Transplantation, 37
J. Cools, D. DeAngelo, J. Gotlib, E. Stover, R. Legare, J. Cortes, J. Kutok, Jennifer Clark, I. Galinsky, J. Griffin, N. Cross, A. Tefferi, J. Malone, R. Alam, S. Schrier, J. Schmid, M. Rose, P. Vandenberghe, G. Verhoef, M. Boogaerts, I. Wlodarska, H. Kantarjian, P. Marynen, S. Coutre, R. Stone, D. Gilliland (2003)
A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.The New England journal of medicine, 348 13
C. Akin, A. Kirshenbaum, T. Semere, A. Worobec, Linda Scott, D. Metcalfe (2000)
Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.Experimental hematology, 28 2
S. Mackey, H. Pride, W. Tyler (1996)
Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A.Archives of Dermatology, 132
P. Johnstone, J. Mican, D. Metcalfe, T. Delaney (1994)
Radiotherapy of Refractory Bone Pain Due to Systemic Mast Cell DiseaseAmerican Journal of Clinical Oncology, 17
B. Hennessy, F. Giles, J. Cortes, S. O'brien, A. Ferrajoli, G. Ossa, G. Garcia-Manero, S. Faderl, H. Kantarjian, S. Verstovsek (2004)
Management of patients with systemic mastocytosis: Review of M. D. Anderson Cancer Center experienceAmerican Journal of Hematology, 77
H. Fonga-Djimi, F. Gottrand, M. Bonnevalle, J. Farriaux (1995)
A fatal case of portal hypertension complicating systemic mastocytosis in an adolescentEuropean Journal of Pediatrics, 154
Youl-Nam Lee, Stephanie Brandal, P. Noel, E. Wentzel, J. Mendell, M. McDevitt, R. Kapur, M. Carter, D. Metcalfe, C. Takemoto (2011)
KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.Blood, 117 13
T. Wilson, D. Metcalfe, J. Robyn (2006)
Treatment of systemic mastocytosis.Immunology and allergy clinics of North America, 26 3
H. Horny, P. Valent (2002)
Histopathological and Immunohistochemical Aspects of MastocytosisInternational Archives of Allergy and Immunology, 127
Ashraf Uzzaman, I. Maric, P. Noel, B. Kettelhut, D. Metcalfe, M. Carter (2009)
Pediatric‐onset mastocytosis: A long term clinical follow‐up and correlation with bone marrow histopathologyPediatric Blood & Cancer, 53
C. Li (2001)
Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry.Leukemia research, 25 7
L. Schwartz (2001)
Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders.Leukemia research, 25 7
K. Brockow, C. Akin, M. Huber, D. Metcalfe (2005)
IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis.Clinical immunology, 115 2
S. Verstovsek, A. Tefferi, J. Cortes, S. O'brien, G. Garcia-Manero, A. Pardanani, C. Akin, S. Faderl, T. Manshouri, D. Thomas, H. Kantarjian (2008)
Phase II Study of Dasatinib in Philadelphia Chromosome–Negative Acute and Chronic Myeloid Diseases, Including Systemic MastocytosisClinical Cancer Research, 14
K. Gleixner, M. Mayerhofer, K. Aichberger, S. Derdak, K. Sonneck, A. Böhm, A. Gruze, P. Samorapoompichit, P. Manley, D. Fabbro, W. Pickl, C. Sillaber, P. Valent (2006)
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects.Blood, 107 2
P. Valent, M. Ghannadan, C. Akin, M. Krauth, E. Selzer, M. Mayerhofer, W. Sperr, M. Arock, P. Samorapoompichit, Hans-Peter Horny, D. Metcalfe (2004)
On the way to targeted therapy of mast cell neoplasms: identification of molecular targets in neoplastic mast cells and evaluation of arising treatment conceptsEuropean Journal of Clinical Investigation, 34
M. Carter, Sarah Clayton, Hirsh Komarow, E. Brittain, L. Scott, Daly Cantave, Donna Gaskins, I. Maric, D. Metcalfe (2015)
Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.The Journal of allergy and clinical immunology, 136 6
Yongsheng Ma, S. Zeng, D. Metcalfe, C. Akin, S. Dimitrijević, J. Butterfield, G. Mcmahon, B. Longley (2002)
The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations.Blood, 99 5
A. Pardanani (2015)
Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 90
L. Sánchez-Muñoz, Cristina Teodosio, J. Morgado, L. Escribano (2011)
Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders.Methods in cell biology, 103
C. Bodemer, O. Hermine, F. Palmérini, Ying Yang, C. Grandpeix‐Guyodo, P. Leventhal, S. Hadj-Rabia, L. Nasca, S. Georgin-lavialle, A. Cohen-Akenine, J. Launay, S. Barete, F. Féger, M. Arock, B. Catteau, B. Sans, J. Stalder, F. Skowron, L. Thomas, G. Lorette, P. Plantin, P. Bordigoni, O. Lortholary, Y. Prost, A. Moussy, H. Sobol, P. Dubreuil (2010)
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.The Journal of investigative dermatology, 130 3
J. Achord, H. Langford (1980)
The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis.The American journal of medicine, 69 4
J. Gotlib, C. Berubé, J. Growney, C. Chen, T. George, Christopher Williams, T. Kajiguchi, J. Ruan, S. Lilleberg, J. Durocher, J. Lichy, Yanfeng Wang, P. Cohen, D. Arber, M. Heinrich, L. Neckers, S. Galli, D. Gilliland, S. Coutre (2005)
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.Blood, 106 8
D. Przepiorka, S. Giralt, I. Khouri, R. Champlin, C. Bueso-Ramos (1998)
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: Review of forty casesAmerican Journal of Hematology, 57
Ken-Hong Lim, A. Pardanani, J. Butterfield, chin-Yang Li, A. Tefferi (2009)
Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate or 2‐chlorodeoxyadenosineAmerican Journal of Hematology, 84
J. Mican, A. Bisceglie, T. Fong, W. Travis, D. Kleiner, B. Baker, D. Metcalfe (1995)
Hepatic involvement in mastocytosis: Clinicopathologic correlations in 41 casesHepatology, 22
M. Frieri, D. Alling, D. Metcalfe (1985)
Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial.The American journal of medicine, 78 1
A. Hochhaus, M. Baccarani, F. Giles, P. Coutre, Martin Müller, A. Reiter, Helene Santanastasio, M. Leung, S. Novick, H. Kantarjian (2015)
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration studyJournal of Cancer Research and Clinical Oncology, 141
F. Féger, A. Dumas, Laurence Leriche, P. Valent, M. Arock (2002)
Kit and c-kit Mutations in Mastocytosis: A Short Overview with Special Reference to Novel Molecular and Diagnostic ConceptsInternational Archives of Allergy and Immunology, 127
A. Pardanani, A. Tefferi (2010)
A critical reappraisal of treatment response criteria in systemic mastocytosis and a proposal for revisionsEuropean Journal of Haematology, 84
Philipp Guenther, A. Huebner, S. Sobottka, Volker Neumeister, G. Weissbach, H. Todt, R. Parwaresch (2001)
Temporary Response of Localized Intracranial Mast Cell Sarcoma to Combination ChemotherapyJournal of Pediatric Hematology/Oncology, 23
B. Kettelhut, Robert Parker, William Travis, D. Metcalfe (1989)
Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.American journal of clinical pathology, 91 5
Katharina Blatt, S. Cerny‐Reiterer, J. Schwaab, K. Sotlar, G. Eisenwort, G. Stefanzl, G. Hoermann, M. Mayerhofer, M. Schneeweiss, S. Knapp, T. Rülicke, E. Hadzijusufovic, K. Bauer, D. Smiljkovic, M. Willmann, A. Reiter, H. Horny, P. Valent (2015)
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.Blood, 126 26
Karen Chisholm, J. Merker, J. Gotlib, G. Gitana, M. Lefterova, J. Zehnder, T. George, D. Arber, R. Ohgami (2015)
Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.American journal of clinical pathology, 143 4
D. Metcalfe (2008)
Mast cells and mastocytosis.Blood, 112 4
Y. Mekori, A. Gilfillan, C. Akin, K. Hartmann, D. Metcalfe (2001)
Human Mast Cell Apoptosis Is Regulated Through Bcl-2 and Bcl-XLJournal of Clinical Immunology, 21
H. Kudo, S. Morinaga, Y. Shimosato, M. Noguchi, Yasuyuki Mizutani, H. Asamura, T. Naruke (1988)
Solitary mast cell tumor of the lungCancer, 61
Systemic mastocytosis is a clonal disorder of mast cells that may variably present with characteristic skin lesions, episodes of mast cell mediator release, and disturbances of hematopoiesis. No curative therapy presently exists. Conventional management has relied on agents that antagonize mediators released by mast cells, inhibit mediator secretion, or modulate mast cell proliferation. Recent advances in the molecular understanding of the pathophysiology of systemic mastocytosis have provided new therapeutic considerations, including new and novel tyrosine kinase inhibitors.
Annual Review of Pathology: Mechanisms of Disease – Annual Reviews
Published: Jan 24, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.